IRIS
MURA, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 442
EU - Europa 264
AS - Asia 229
Continente sconosciuto - Info sul continente non disponibili 1
Totale 936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 437
CN - Cina 205
IE - Irlanda 167
FI - Finlandia 36
DE - Germania 23
IT - Italia 22
SG - Singapore 13
CA - Canada 5
BE - Belgio 4
IN - India 4
UA - Ucraina 4
FR - Francia 2
GB - Regno Unito 2
IQ - Iraq 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
IR - Iran 1
MD - Moldavia 1
MN - Mongolia 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 936
Salva come PNG Salva come JPEG
Città #
Dublin 167
Chandler 118
Beijing 46
Nanjing 44
New York 34
Helsinki 26
Wilmington 26
Ashburn 25
Boardman 25
Lawrence 21
Princeton 21
Pavia 20
Medford 19
Shanghai 19
Nanchang 16
Jacksonville 15
Shenyang 15
Changsha 14
Jiaxing 14
Hebei 11
Tianjin 9
Hangzhou 7
Fairfield 6
Singapore 6
Ann Arbor 4
Brussels 4
Piscataway 4
Toronto 4
Dearborn 3
Falls Church 3
Woodbridge 3
Zhengzhou 3
Baghdad 2
Frankfurt am Main 2
Norwalk 2
Seattle 2
Tokyo 2
Washington 2
Berlin 1
Bern 1
Brierley Hill 1
Cambridge 1
Dallas 1
Des Moines 1
Edmonton 1
Esslingen am Neckar 1
Hefei 1
Houston 1
Jaipur 1
Las Vegas 1
Mountain View 1
Redwood City 1
Ulaanbaatar 1
Walnut 1
Zgierz 1
Totale 781
Salva come PNG Salva come JPEG
Nome #
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 68
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 61
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 60
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 57
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 50
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 50
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 50
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 50
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 50
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 44
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 43
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 41
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 41
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 41
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 37
Tuning tissue ingrowth into pro-angiogenic hydrogels via dual modality degradation 36
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 36
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 34
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection 24
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 24
null 11
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 7
Totale 1.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020157 0 91 0 8 2 4 1 4 11 18 18 0
2020/202142 3 0 0 0 8 8 2 12 7 2 0 0
2021/202299 0 0 4 0 3 3 1 9 3 0 16 60
2022/2023378 38 33 8 17 30 32 0 20 183 2 10 5
2023/2024156 28 24 7 5 9 52 5 11 0 2 7 6
2024/202537 13 24 0 0 0 0 0 0 0 0 0 0
Totale 1.009